Program Development Centre, CIRO+, Centre of Expertise for Chronic Organ Failure, Horn, The Netherlands; Proteion Thuis, Horn, The Netherlands; CAPHRI, Maastricht University, Maastricht, The Netherlands.
Program Development Centre, CIRO+, Centre of Expertise for Chronic Organ Failure, Horn, The Netherlands.
Chest. 2011 May;139(5):1081-1088. doi: 10.1378/chest.10-1753. Epub 2010 Sep 9.
Patients with severe COPD or chronic heart failure (CHF) are often confronted with decisions concerning life-sustaining treatments. The aim of this prospective, observational study was to assess life-sustaining treatment preferences, advance care planning, and the quality of end-of-life care communication in Dutch outpatients with clinically stable but severe COPD or CHF.
The following outcomes were assessed in outpatients with severe COPD (n = 105) or CHF (n = 80): life-sustaining treatment preferences (CPR and mechanical ventilation; Willingness to Accept Life-sustaining Treatment instrument), advance care planning, and quality of end-of-life care communication (Quality of Communication questionnaire).
Most patients asserted that in their current health status, they would prefer CPR (COPD, 70.5%; CHF, 62.5%) and/or mechanical ventilation (COPD, 70.5%; CHF, 66.3%). Patients' treatment preferences were influenced by burden of treatment, outcome of treatment, and likelihood of outcome. Advance directives were discussed with the physician specialist by 5.9% of patients with COPD and 3.9% of patients with CHF. Patients rated quality of patient-physician end-of-life care communication as poor. Physicians rarely discussed prognosis, dying, and palliative care.
Despite the fact that patients are able to indicate their preferences regarding life-sustaining treatments, based on burden of treatment, outcome of treatment, and likelihood of outcome, these preferences are rarely discussed with their physician specialist. This study shows a need for advance care planning, taking into account the burden of treatment, outcome of treatment, and likelihood of outcome, in patients with severe COPD or CHF. Finally, the quality of patient-physician end-of-life care communication needs to improve.
患有严重 COPD 或慢性心力衰竭 (CHF) 的患者通常需要面临有关维持生命治疗的决策。本前瞻性观察研究的目的是评估荷兰临床稳定但患有严重 COPD 或 CHF 的门诊患者的维持生命治疗偏好、预先护理计划和生命末期护理沟通质量。
在严重 COPD(n=105)或 CHF(n=80)门诊患者中评估以下结局:维持生命治疗偏好(CPR 和机械通气;接受维持生命治疗意愿量表)、预先护理计划和生命末期护理沟通质量(沟通质量问卷)。
大多数患者表示,在他们目前的健康状况下,他们更愿意接受 CPR(COPD,70.5%;CHF,62.5%)和/或机械通气(COPD,70.5%;CHF,66.3%)。患者的治疗偏好受治疗负担、治疗结果和结果可能性的影响。5.9%的 COPD 患者和 3.9%的 CHF 患者与医师专家讨论了预先指示。患者对医患生命末期护理沟通质量的评价较差。医师很少讨论预后、死亡和姑息治疗。
尽管患者能够根据治疗负担、治疗结果和结果可能性表明其对维持生命治疗的偏好,但这些偏好很少与他们的医师专家讨论。这项研究表明,在严重 COPD 或 CHF 患者中,需要进行预先护理计划,考虑治疗负担、治疗结果和结果可能性。最后,医患生命末期护理沟通质量需要提高。